Literature DB >> 29165657

Rotavirus Vaccination Can Be Performed Without Viral Dissemination in the Neonatal Intensive Care Unit.

Hiroyuki Hiramatsu1, Ryota Suzuki1, Arisa Nagatani2, Hiroko Boda2, Masafumi Miyata2, Fumihiko Hattori2, Hiroki Miura2, Ken Sugata2, Shigeki Yamada1, Satoshi Komoto3, Koki Taniguchi3, Masaru Ihira4, Naoko Nishimura5, Takao Ozaki5, Tetsushi Yoshikawa2.   

Abstract

Background: This study was conducted to assess the transmissibility of rotavirus vaccine strains after rotavirus vaccination in a neonatal intensive care unit (NICU).
Methods: Pentavalent (RV5) or monovalent (RV1) rotavirus vaccine was administered to infants admitted to the NICU. Nineteen vaccinated infants and 49 unvaccinated infants whose beds were located in close proximity to the vaccinated infants were enrolled in this study. Dissemination and fecal shedding of vaccine viruses within the NICU were examined using real-time reverse transcription-polymerase chain reaction.
Results: Shedding of the vaccine strain was detected in all 19 vaccinated infants. RV5 virus shedding started 1 day after the first vaccination and persisted for 8 days after the first vaccination, and viral shedding terminated by day 5 after administration of the second RV5 dose. The kinetics of RV1 virus shedding differed among vaccinated infants. The duration of RV1 virus shedding was longer after the first vaccination than after the second vaccination. In contrast to the vaccinated infants, no vaccine virus genomes were detected in any of the stool samples collected from the 49 unvaccinated infants. Conclusions: This study is direct evidence of no transmission of rotavirus vaccine strains between vaccinated infants and unvaccinated infants in close proximity within a NICU.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Rotavirus; horizontal transmission; neonatal intensive care unit; vaccine; viral excretion

Mesh:

Substances:

Year:  2018        PMID: 29165657     DOI: 10.1093/infdis/jix590

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Rotavirus Vaccination Coverage During a Rotavirus Outbreak Resulting in a Fatality at a Subacute Care Facility.

Authors:  Rachel M Burke; Jacqueline E Tate; George S Han; Rebecca Quenelle; Rashi Gautam; Debra A Wadford; Michael D Bowen; Umesh D Parashar
Journal:  J Pediatric Infect Dis Soc       Date:  2020-07-13       Impact factor: 3.164

2.  Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Authors:  Karla Soares-Weiser; Hanna Bergman; Nicholas Henschke; Femi Pitan; Nigel Cunliffe
Journal:  Cochrane Database Syst Rev       Date:  2019-10-28

3.  Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Authors:  Karla Soares-Weiser; Hanna Bergman; Nicholas Henschke; Femi Pitan; Nigel Cunliffe
Journal:  Cochrane Database Syst Rev       Date:  2019-03-25

4.  Incidence, Clinical Characteristics, and Genotype Distribution of Rotavirus in a Neonatal Intensive Care Unit 5 Years After Introducing Rotavirus Vaccine.

Authors:  Hye Sun Yoon; Jiseun Lim; Yong-Hak Sohn; Seung Yeon Kim
Journal:  Front Pediatr       Date:  2022-02-17       Impact factor: 3.418

5.  Case Report: Rotavirus Vaccination and Severe Combined Immunodeficiency in Japan.

Authors:  Kay Tanita; Yoshiki Kawamura; Hiroki Miura; Noriko Mitsuiki; Takahiro Tomoda; Kento Inoue; Akihiro Iguchi; Masafumi Yamada; Taro Yoshida; Hideki Muramatsu; Norimasa Tada; Toshihiro Matsui; Motohiro Kato; Katsuhide Eguchi; Masataka Ishimura; Shouichi Ohga; Kohsuke Imai; Tomohiro Morio; Tetsushi Yoshikawa; Hirokazu Kanegane
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

Review 6.  Immunization of preterm infants: current evidence and future strategies to individualized approaches.

Authors:  Mats Ingmar Fortmann; Johannes Dirks; Sybelle Goedicke-Fritz; Johannes Liese; Michael Zemlin; Henner Morbach; Christoph Härtel
Journal:  Semin Immunopathol       Date:  2022-08-03       Impact factor: 11.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.